Shares of NervGen Pharma Corp. (traded on the NASDAQ exchange under the ticker symbol NGEN) trade at approximately $2.02 per share. Intraday trading values fluctuate dynamically based on clinical trial development updates, micro-cap biotechnology sector volume shifts, and periodic financial disclosures filed with regulatory authorities.